When: Wednesday, December 20, 2017 from 5:00 PM to 7:00 PM
Where: Bar Louie 150 Gibbs St Rockville, MD 20850
Join BioBuzz and annual sponsor Biohealth Innovation, Inc. to celebrate the holiday season and last BioBuzz event of the year. The celebration will be at Bar Louie in the Rockville Town Center on December 20th, 2017 from 5 – 7pm. Only a 5 minute walk from the Rockville Metro, please join us for this exciting event.
The Emmes Corporation today announced that it was named one of the top women-owned businesses in the Washington metropolitan area by the Washington Business Journal. The company was ranked as the seventh largest women-owned business in the Washington region, up from number eight last year.
As secretary for the Department of Health and Human Services (HHS), Alex Azar would oversee a trillion-dollar budget, over 90,000 employees, and a healthcare system that is ground-zero for heated bipartisan politics.
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is pleased to announce Immunomic’s founder and CEO, William Hearl, Ph.D., has been appointed by Governor Larry Hogan to the Maryland Department of Commerce Life Sciences Advisory Board (LSAB).
U.S. drugmaker Merck & Co. and German diagnostics firm Qiagen are separately planning major investments in the U.K. The moves accompany a raft of British government measures intended to bolster the life sciences sector as the country prepares to leave the European Union.
In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area. Here’s a roundup of all of the major funding news from the region in November:
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that the Company has entered an exclusive, worldwide license agreement with MedImmune, the global biologics research and development arm of AstraZeneca, for PB2452 (formerly MEDI2452), a Phase 1-ready reversal agent for ticagrelor.
Complex tissues. Surprisingly simple.
Enabling you to study complex 3D tissue biology in a simple device, that’s our goal. With perfused vessels, co-culture and optimized microenvironments. So easy to use that you forget you’re working with a highly advanced 3D culture platform. With the OrganoPlate®, we believe we’ve reached that goal. Say hello to the future of 3D tissue models.
What makes the body of a person or any other organism work can for the most part be summed up in a word: proteins.
These big molecules carry out almost all processes in living organisms, including moving other molecules from one place to another, replicating DNA, conveying genetic information from genes to cells, controlling immune response, driving metabolism and building muscle. Not all protein molecules are created equal, though, and some are better understood than others.
A medical device developer has created a $10-million venture capital fund to support early stage health care companies.
Holland-based Genesis Innovation Group said today it established the privately funded cultivate(MD) Capital Fund I, LLC, which will focus on medical device and orthopedic technologies.
